Literature DB >> 16903905

The immunoregulatory effects of Qa-1.

Linrong Lu1, Miriam B F Werneck, Harvey Cantor.   

Abstract

The immune system is not only well equipped to control infections but also tightly controlled to prevent autoimmune disease. Despite the negative selection of T-cell clones in the thymus, mature T cells capable of recognizing self-antigens are present in every individual. Several types of specialized regulatory cells maintain homeostasis and prevent expansion of autoreactive T cells. In this issue of Immunological Reviews, the role of CD4+ regulatory T cells is extensively discussed. Suppression of T-cell responses by CD8+ T cells has received less attention. Here, we review research on Qa-1-restricted CD8+ regulatory T cells. We focus on the role of this class Ib major histocompatibility complex (MHC) molecule in both CD8+ regulatory T-cell activity and protection of activated T cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16903905     DOI: 10.1111/j.0105-2896.2006.00418.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  30 in total

1.  Phenotypic changes to the endogenous antigen-specific CD8+ T cell response correlates with the development and resolution of allergic airway disease.

Authors:  Jeffrey T McNamara; Craig M Schramm; Anurag Singh; Eric R Secor; Linda A Guernsey; Leo Lefrançois; Roger S Thrall
Journal:  Am J Pathol       Date:  2012-03-24       Impact factor: 4.307

2.  Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway.

Authors:  Linrong Lu; Koichi Ikizawa; Dan Hu; Miriam B F Werneck; Kai W Wucherpfennig; Harvey Cantor
Journal:  Immunity       Date:  2007-05       Impact factor: 31.745

3.  Regulation of CD8+ regulatory T cells: Interruption of the NKG2A-Qa-1 interaction allows robust suppressive activity and resolution of autoimmune disease.

Authors:  Linrong Lu; Hye-Jung Kim; Miriam B F Werneck; Harvey Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-01       Impact factor: 11.205

Review 4.  The mechanisms and applications of T cell vaccination for autoimmune diseases: a comprehensive review.

Authors:  Xin Huang; Haijing Wu; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

Review 5.  Induction of immune tolerance by activation of CD8+ T suppressor/regulatory cells in lupus-prone mice.

Authors:  Brian J Skaggs; Ram Pyare Singh; Bevra H Hahn
Journal:  Hum Immunol       Date:  2008-09-24       Impact factor: 2.850

Review 6.  Inhibitory CD8+ T cells in autoimmune disease.

Authors:  Masakatsu Suzuki; Christine Konya; Jörg J Goronzy; Cornelia M Weyand
Journal:  Hum Immunol       Date:  2008-09-21       Impact factor: 2.850

Review 7.  Pathways of major histocompatibility complex allorecognition.

Authors:  Behdad Afzali; Giovanna Lombardi; Robert I Lechler
Journal:  Curr Opin Organ Transplant       Date:  2008-08       Impact factor: 2.640

8.  Small intestinal CD8+TCRgammadelta+NKG2A+ intraepithelial lymphocytes have attributes of regulatory cells in patients with celiac disease.

Authors:  Govind Bhagat; Afzal J Naiyer; Jayesh G Shah; Jason Harper; Bana Jabri; Timothy C Wang; Peter H R Green; John S Manavalan
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

9.  NKG2A inhibits invariant NKT cell activation in hepatic injury.

Authors:  Toshihiko Kawamura; Kazuyoshi Takeda; Hiroshi Kaneda; Hiroaki Matsumoto; Yoshihiro Hayakawa; David H Raulet; Yoshinori Ikarashi; Mitchell Kronenberg; Hideo Yagita; Katsuyuki Kinoshita; Toru Abo; Ko Okumura; Mark J Smyth
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

10.  The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects.

Authors:  Cláudia C Oliveira; Peter A van Veelen; Bianca Querido; Arnoud de Ru; Marjolein Sluijter; Sandra Laban; Jan W Drijfhout; Sjoerd H van der Burg; Rienk Offringa; Thorbald van Hall
Journal:  J Exp Med       Date:  2009-12-28       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.